![\"bmkpharmaceremony-2050\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/10\/bmkpharmaceremony-2050.JPG;w=960.jpeg\"\/)
\nPhoto: BMK Pharma <\/p>\n
The new facility will expand pharmaceutical production and create more than 100 jobs \n<\/p>\n
A new pharmaceutical manufacturing operation is taking shape in Allen, bringing a multimillion-dollar investment and more than 100 specialized jobs to the city. BMK Pharma is developing a roughly 50,000-square-foot facility that will combine sterile drug manufacturing, pharmaceutical development and contract manufacturing under one roof.<\/p>\n
The approximately $50 million project, located near Exchange Parkway and U.S. Highway 75, is expected to be completed in summer 2027. Once operational, the facility will focus on producing medications for healthcare providers while supporting pharmaceutical and biotechnology companies with drug development and manufacturing services.<\/p>\n
Founded by Dr. Jay Bhaumik, BMK Pharma aims to expand domestic pharmaceutical production and contribute to a more reliable medication supply chain.<\/p>\n
“We are building the facility in Allen because we see tremendous room for opportunity here,” Bhaumik said in an official statement. “Allen will become an important home for our pharmaceutical operations, and we are excited to continue investing in this community.”<\/p>\n
What Will BMK Pharma Manufacture In Allen?<\/p>\n
Unlike a traditional retail pharmacy, BMK Pharma’s Allen operation is being developed to manufacture medications on a larger scale. The company plans to operate a 503B outsourcing facility, a type of pharmaceutical operation that can produce compounded medications in batches for hospitals, clinics and other healthcare providers. These facilities are subject to U.S. Food and Drug Administration oversight and must comply with current Good Manufacturing Practices (cGMP).<\/p>\n
The Allen facility will specialize in sterile pharmaceutical manufacturing, including injectable medications and other dosage forms. It will also incorporate automation and advanced manufacturing technology into its production processes.<\/p>\n
Beyond producing medications, BMK Pharma will offer contract development and manufacturing organization (CDMO) services. Pharmaceutical and biotechnology companies will be able to work with BMK Pharma without operating their own production facilities.<\/p>\n
Strengthening The Pharmaceutical Supply Chain<\/p>\n
The Allen project comes as pharmaceutical manufacturers and healthcare providers continue looking for ways to improve access to essential medications and strengthen domestic production.<\/p>\n
BMK Pharma says its manufacturing capabilities are intended to support medication availability, improve affordability and reduce supply chain vulnerabilities by expanding production capacity within the United States.<\/p>\n
The company is particularly focused on sterile medications, including injectable drugs used by healthcare providers. Although the facility is not yet operational, its planned manufacturing capabilities could contribute additional domestic production capacity as the pharmaceutical industry works to address supply challenges.<\/p>\n
\nPhoto: BMK Pharma
<\/p>\n
More Than 100 Jobs Coming To Allen<\/p>\n
The facility is expected to support more than 100 high-skilled positions across pharmaceutical manufacturing, chemistry, engineering, automation, pharmacy and research. According to the\u00a0Allen Economic Development Corporation<\/a>, BMK Pharma selected Allen for its skilled workforce, business environment and local economic development support.<\/p>\n Construction is already underway, and company representatives joined Allen Mayor Chris Schulmeister and local economic development leaders on Oct. 1 to mark progress at the site.<\/p>\n The project is part of Allen’s efforts to attract advanced manufacturing and technology-focused businesses, adding pharmaceutical production to the city’s expanding commercial landscape.<\/p>\n The latest company announcement places completion in summer 2027, although a specific date for the start of manufacturing operations has not been announced.<\/p>\n More information about the company is available at BMK Pharma’s official website<\/a>.<\/p>\n